Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up
Open Access
- 1 January 1993
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 3 (1) , 44-53
- https://doi.org/10.1046/j.1525-1438.1993.03010044.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerCancer Chemotherapy and Pharmacology, 1990
- Speed of response to platinum-based chemotherapy: Implications for the management of epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimenEuropean Journal of Cancer and Clinical Oncology, 1987
- HAC-cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating Chemotherapy With IntensificationCancer, 1985
- Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studiesCancer, 1984
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum-based combinationCancer, 1982
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981
- Surgery for common epithelial tumors of the ovaryCancer, 1981
- Evaluating differences in survival between two groups of patientsJournal of Chronic Diseases, 1971